FT  08 JAN 94 / UK Company News: Medeva and Proteus in joint venture
Medeva, the pharmaceuticals company, and Proteus International, the
computer-aided molecular modelling group, have formed Beavermade, a 50:50
joint venture company.
Beavermade was created by the two companies to combine their expertise in
the production of new synthetic vaccines and therapeutics for humans.
Initially it will concentrate on an oral hepatitis B vaccine and a new
hepatitis C vaccine.
